126 related articles for article (PubMed ID: 20615582)
1. Synthesis and biological evaluation of cyclic nitrogen mustards based on carnitine framework.
Leiris S; Lucas M; Dupuy d'Angeac A; Morère A
Eur J Med Chem; 2010 Sep; 45(9):4140-8. PubMed ID: 20615582
[TBL] [Abstract][Full Text] [Related]
2. New nitrogen mustards structurally related to (L)-carnitine.
Faissat L; Martin K; Chavis C; Montéro JL; Lucas M
Bioorg Med Chem; 2003 Feb; 11(3):325-34. PubMed ID: 12517428
[TBL] [Abstract][Full Text] [Related]
3. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.
Ware DC; Palmer HR; Pruijn FB; Anderson RF; Brothers PJ; Denny WA; Wilson WR
Anticancer Drug Des; 1998 Mar; 13(2):81-103. PubMed ID: 9524553
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of a nitrogen mustard derivative stabilized by apo-neocarzinostatin.
Urbaniak MD; Bingham JP; Hartley JA; Woolfson DN; Caddick S
J Med Chem; 2004 Sep; 47(19):4710-5. PubMed ID: 15341486
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents.
Zheng QZ; Zhang F; Cheng K; Yang Y; Chen Y; Qian Y; Zhang HJ; Li HQ; Zhou CF; An SQ; Jiao QC; Zhu HL
Bioorg Med Chem; 2010 Jan; 18(2):880-6. PubMed ID: 20005116
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure-activity relationship and biological evaluation of novel nitrogen mustard sophoridinic acid derivatives as potential anticancer agents.
Li DD; Dai LL; Zhang N; Tao ZW
Bioorg Med Chem Lett; 2015 Oct; 25(19):4092-6. PubMed ID: 26299348
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of novel nitrogen mustard-linked chalcones.
Fang X; Yang B; Cheng Z; Yang M; Su N; Zhou L; Zhou J
Arch Pharm (Weinheim); 2013 Apr; 346(4):292-9. PubMed ID: 23519571
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis of a potential metabolite of the carcinostatic bendamustin (Cytostasen)].
Werner W; Letsch G; Ihn W; Sohr R; Preiss R
Pharmazie; 1991 Feb; 46(2):113-4. PubMed ID: 1852759
[TBL] [Abstract][Full Text] [Related]
10. Nitrogen Mustards as Anticancer Chemotherapies: Historic Perspective, Current Developments and Future Trends.
Diethelm-Varela B; Ai Y; Liang D; Xue F
Curr Top Med Chem; 2019; 19(9):691-712. PubMed ID: 30931858
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.
Ware DC; Palmer BD; Wilson WR; Denny WA
J Med Chem; 1993 Jun; 36(13):1839-46. PubMed ID: 8515422
[TBL] [Abstract][Full Text] [Related]
12. Derivatives of nitrogen mustard anticancer agents with improved cytotoxicity.
Antoni F; Bernhardt G
Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000366. PubMed ID: 33283341
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Quazi GN; Sanyal U
Acta Pol Pharm; 2003; 60(4):285-91. PubMed ID: 14714857
[TBL] [Abstract][Full Text] [Related]
14. Nitro analogues of chlorambucil as potential hypoxia-selective anti-tumour drugs.
Palmer BD; Wilson WR; Denny WA
Anticancer Drug Des; 1990 Nov; 5(4):337-49. PubMed ID: 2291774
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA
J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs.
Hu L; Wu X; Han J; Chen L; Vass SO; Browne P; Hall BS; Bot C; Gobalakrishnapillai V; Searle PF; Knox RJ; Wilkinson SR
Bioorg Med Chem Lett; 2011 Jul; 21(13):3986-91. PubMed ID: 21620697
[TBL] [Abstract][Full Text] [Related]
17. Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies.
Baraldi PG; Beria I; Cozzi P; Geroni C; Espinosa A; Gallo MA; Entrena A; Bingham JP; Hartley JA; Romagnoli R
Bioorg Med Chem; 2004 Jul; 12(14):3911-21. PubMed ID: 15210158
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.
Baraldi PG; Romagnoli R; Beria I; Cozzi P; Geroni C; Mongelli N; Bianchi N; Mischiati C; Gambari R
J Med Chem; 2000 Jul; 43(14):2675-84. PubMed ID: 10893305
[TBL] [Abstract][Full Text] [Related]
19. Potential anticancer agents. XX. 2. Quantitative structure--activity relationships (QSAR) in aromatic nitrogen mustards area.
Niculescu-Duvăz I; Stihi G; Crăescu T; Simon Z
Neoplasma; 1980; 27(3):271-8. PubMed ID: 7453847
[TBL] [Abstract][Full Text] [Related]
20. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ
J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]